ReviewDiscover nano2025
Environmentally friendly synthesis of quantum dots and their applications in diverse fields from the perspective of environmental compliance: A review.
Review in Discover nano, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Excitonic and Optical Transduction Mechanisms in Quantum Dot Sensors for Environmental Pollutant Detection.Sensors (Basel, Switzerland) · 2026Review
- Advances in green-synthesized quantum dot-based nanoplatforms for cancer treatment, photodynamic therapy, photothermal therapy and cancer theranostics.RSC advances · 2026Review
- Preparation of Monolithic Silica Nanocomposite Plates Embedding Fluorescent Graphene Quantum Dots via an Aqueous Sol-Gel Process.ACS omega · 2026Article
- Recent advances in hybrid nano-interfaces for environmental pollutant detection: design principles, signal transduction, and analytical performance.Mikrochimica acta · 2026Review
- Indium phosphide quantum dots: advanced synthesis, surface engineering, and biomedical applications in imaging, sensing, and therapy.RSC advances · 2026Review
- The Epigenomic Impact of Quantum Dots: Emerging Biosensors and Potential Disruptors.Epigenomes · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Semiconductor Quantum-dots (QDs), characterized by their unique optoelectronic tunability, high efficiency, and multifunctionality, have emerged as transformative materials in diverse fields, including display technologies, energy conversion, solar cells, biomedical applications, and quantum technologies. With ongoing advancements in material synthesis and device engineering, the application scope of QDs is anticipated to expand further, thereby driving interdisciplinary technological innovations and fostering breakthroughs across multiple scientific fields. However, in recent years, the rapid development of Cd, Pb, and Hg-based QDs has raised significant environmental and biological concerns due to the inherent toxicity of these heavy metals. Consequently, these materials have been classified as restricted substances by major global entities, including international organizations, the European Union, and the United States, through international treaties and domestic legislation. To mitigate legal risks associated with environmental pollution, the development of non-toxic and environmentally friendly (eco-friendly) QDs has become imperative. This review focuses on several eco-friendly QDs, such as indium phosphide (InP), copper indium sulfide (CuInS₂), and graphene QDs (GQDs), from the perspective of environmental compliance. It comprehensively discusses their synthesis methods, application domains, and the advantages and disadvantages of different preparation techniques, along with their environmental impacts. Finally, the review summarizes the existing challenges, limitations, and potential solutions for the development of environmentally benign QDs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.